微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.79% | 22.91% | 95.1% | 55/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.43% | 12.6% | -68.64% | 60/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 4.56% | 44.76% | -20.83% | 59/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 5.76% | 14.29% | 153.74% | 49/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 2.27% | 35.12% | 78.74% | 66/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.27% | 23.3% | -59.68% | 64/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.15% | 21.62% | -37.5% | 79/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 5.04% | 1.41% | 200% | 54/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.68% | 90.91% | 63.11% | 82/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.03% | 128.89% | -60.23% | 75/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.59% | 96.21% | -47.89% | 92/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.97% | 0.61% | 464.77% | 65/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.88% | -35.29% | 95.56% | 104/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.45% | -62.81% | -65.91% | 101/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 1.32% | -80.36% | -73.28% | 110/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 4.94% | -42.42% | 263.24% | 86/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.36% | -69.71% | 12.4% | 104/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.21% | -47.84% | -81.99% | 82/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.72% | -40.64% | -21.68% | 100/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 8.58% | 2% | 91.09% | 69/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 4.49% | 63.87% | 93.53% | 84/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.32% | 2% | -79.51% | 67/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 11.32% | -42.48% | 313.14% | 82/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 2.74% | -67.76% | -86.08% | 90/141 | 15.17% | 圣湘生物 | 112.46% | 行业排名> |
| 2019-12-31 | 19.68% | 63.46% | 131.53% | 41/141 | 14.66% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2019-06-30 | 8.5% | 241.37% | -29.4% | 22/141 | 6.76% | 圣湘生物 | 29.33% | 行业排名> |
| 2018-12-31 | 12.04% | 9.55% | 383.53% | 61/141 | 14.23% | 健尔康 | 84.09% | 行业排名> |
| 2018-06-30 | 2.49% | -57.8% | -77.34% | 46/141 | 4.54% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2017-12-31 | 10.99% | -24.21% | 86.27% | 62/141 | 14.51% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-06-30 | 5.9% | 2.08% | -59.31% | 29/141 | 6.11% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 14.5% | 2.11% | 150.87% | 37/141 | 16.44% | 安旭生物 | 48.71% | 行业排名> |
| 2016-06-30 | 5.78% | 59.67% | -59.3% | 22/141 | 6.35% | 迈瑞医疗 | 38.33% | 行业排名> |